132 related articles for article (PubMed ID: 36240077)
1. Imaging Features in the Liver after Stereotactic Body Radiation Therapy.
Navin PJ; Olson MC; Mendiratta-Lala M; Hallemeier CL; Torbenson MS; Venkatesh SK
Radiographics; 2022; 42(7):2131-2148. PubMed ID: 36240077
[TBL] [Abstract][Full Text] [Related]
2. Imaging post-stereotactic body radiation therapy responses for hepatocellular carcinoma: typical imaging patterns and pitfalls.
Mastrocostas K; Jang HJ; Fischer S; Dawson LA; Munoz-Schuffenegger P; Sapisochin G; Kim TK
Abdom Radiol (NY); 2019 May; 44(5):1795-1807. PubMed ID: 30710166
[TBL] [Abstract][Full Text] [Related]
3. Magnetic Resonance Imaging Evaluation of Hepatocellular Carcinoma Treated With Stereotactic Body Radiation Therapy: Long Term Imaging Follow-Up.
Mendiratta-Lala M; Masch W; Shankar PR; Hartman HE; Davenport MS; Schipper MJ; Maurino C; Cuneo KC; Lawrence TS; Owen D
Int J Radiat Oncol Biol Phys; 2019 Jan; 103(1):169-179. PubMed ID: 30213751
[TBL] [Abstract][Full Text] [Related]
4. Stereotactic body radiation therapy of liver tumors: post-treatment appearances and evaluation of treatment response: a pictorial review.
Haddad MM; Merrell KW; Hallemeier CL; Johnson GB; Mounajjed T; Olivier KR; Fidler JL; Venkatesh SK
Abdom Radiol (NY); 2016 Oct; 41(10):2061-77. PubMed ID: 27167232
[TBL] [Abstract][Full Text] [Related]
5. Stereotactic body radiation therapy vs. radiofrequency ablation in Asian patients with hepatocellular carcinoma.
Kim N; Cheng J; Jung I; Liang J; Shih YL; Huang WY; Kimura T; Lee VHF; Zeng ZC; Zhenggan R; Kay CS; Heo SJ; Won JY; Seong J
J Hepatol; 2020 Jul; 73(1):121-129. PubMed ID: 32165253
[TBL] [Abstract][Full Text] [Related]
6. Stereotactic body radiation therapy (SBRT) for hepatocellular carcinoma: imaging evaluation post treatment.
Kellock T; Liang T; Harris A; Schellenberg D; Ma R; Ho S; Yap WW
Br J Radiol; 2018 May; 91(1085):20170118. PubMed ID: 29334232
[TBL] [Abstract][Full Text] [Related]
7. Stereotactic Body Radiation Therapy for Liver Tumors: Current Status and Perspectives.
Doi H; Beppu N; Kitajima K; Kuribayashi K
Anticancer Res; 2018 Feb; 38(2):591-599. PubMed ID: 29374681
[TBL] [Abstract][Full Text] [Related]
8. Acceptable toxicity after stereotactic body radiation therapy for liver tumors adjacent to the central biliary system.
Eriguchi T; Takeda A; Sanuki N; Oku Y; Aoki Y; Shigematsu N; Kunieda E
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(4):1006-11. PubMed ID: 23102838
[TBL] [Abstract][Full Text] [Related]
9. Imaging Findings Within the First 12 Months of Hepatocellular Carcinoma Treated With Stereotactic Body Radiation Therapy.
Mendiratta-Lala M; Gu E; Owen D; Cuneo KC; Bazzi L; Lawrence TS; Hussain HK; Davenport MS
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):1063-1069. PubMed ID: 29029891
[TBL] [Abstract][Full Text] [Related]
10. Stereotactic body radiotherapy-induced arterial hypervascularity of non-tumorous hepatic parenchyma in patients with hepatocellular carcinoma: potential pitfalls in tumor response evaluation on multiphase computed tomography.
Park MJ; Kim SY; Yoon SM; Kim JH; Park SH; Lee SS; Lee Y; Lee MG
PLoS One; 2014; 9(2):e90327. PubMed ID: 24587326
[TBL] [Abstract][Full Text] [Related]
11. Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.
Venkat PS; Hoffe SE; Frakes JM
Cancer Control; 2017; 24(3):1073274817729259. PubMed ID: 28975831
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic body radiation therapy in recurrent hepatocellular carcinoma.
Huang WY; Jen YM; Lee MS; Chang LP; Chen CM; Ko KH; Lin KT; Lin JC; Chao HL; Lin CS; Su YF; Fan CY; Chang YW
Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):355-61. PubMed ID: 22342300
[TBL] [Abstract][Full Text] [Related]
13. SBRT for HCC: Overview of technique and treatment response assessment.
Shampain KL; Hackett CE; Towfighi S; Aslam A; Masch WR; Harris AC; Chang SD; Khanna K; Mendiratta V; Gabr AM; Owen D; Mendiratta-Lala M
Abdom Radiol (NY); 2021 Aug; 46(8):3615-3624. PubMed ID: 33963419
[TBL] [Abstract][Full Text] [Related]
14. A Pilot Trial Evaluating Stereotactic Body Radiation Therapy to Induce Hyperemia in Combination With Transarterial Chemoembolization for Hepatocellular Carcinoma.
Sebastian NT; Miller ED; Yang X; Diaz DA; Tan Y; Dowell J; Spain J; Rikabi A; Elliott E; Knopp M; Williams TM
Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1276-1283. PubMed ID: 32712254
[TBL] [Abstract][Full Text] [Related]
15. A mid-treatment break and reassessment maintains tumor control and reduces toxicity in patients with hepatocellular carcinoma treated with stereotactic body radiation therapy.
Jackson WC; Suresh K; Maurino C; Feng M; Cuneo KC; Ten Haken RK; Lawrence TS; Schipper MJ; Owen D
Radiother Oncol; 2019 Dec; 141():101-107. PubMed ID: 31431377
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcomes of stereotactic body radiation therapy in the treatment of hepatocellular cancer as a bridge to transplantation.
O'Connor JK; Trotter J; Davis GL; Dempster J; Klintmalm GB; Goldstein RM
Liver Transpl; 2012 Aug; 18(8):949-54. PubMed ID: 22467602
[TBL] [Abstract][Full Text] [Related]
17. A phase 2 multicenter study of stereotactic body radiotherapy for hepatocellular carcinoma: Safety and efficacy.
Jang WI; Bae SH; Kim MS; Han CJ; Park SC; Kim SB; Cho EH; Choi CW; Kim KS; Hwang S; Kim JH; Chang AR; Park Y; Kim ES; Kim WC; Jo S; Park HJ
Cancer; 2020 Jan; 126(2):363-372. PubMed ID: 31747476
[TBL] [Abstract][Full Text] [Related]
18. Stereotactic body radiation therapy for primary liver tumors: An effective liver-directed therapy in the toolbox.
Roberts HJ; Wo JY
Cancer; 2022 Mar; 128(5):956-965. PubMed ID: 34847255
[TBL] [Abstract][Full Text] [Related]
19. Tumor response assessment by MRI following stereotactic body radiation therapy for hepatocellular carcinoma.
Oldrini G; Huertas A; Renard-Oldrini S; Taste-George H; Vogin G; Laurent V; Salleron J; Henrot P
PLoS One; 2017; 12(4):e0176118. PubMed ID: 28441447
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of the therapeutic response after stereotactic body radiation therapy for liver tumors].
Janoray G; Barillot I; Calais G
Cancer Radiother; 2014; 18(4):320-4. PubMed ID: 24811896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]